Five Trade Associations Request Extension from FDA for Filing Comments on NDI Draft Guidance August 1, 2011 | Read more about Five Trade Associations Request Extension from FDA for Filing Comments on NDI Draft Guidance
CRN Submits Comments to FDA, Docket No. FDA-2011-N-0238: Agency Information Collection Activities; Proposed Collection; Comment Request; Preventive Controls for Registered Human Food and Animal Food/Feed Facilities August 17, 2011 | Read more about CRN Submits Comments to FDA, Docket No. FDA-2011-N-0238: Agency Information Collection Activities; Proposed Collection; Comment Request; Preventive Controls for Registered Human Food and Animal Food/Feed Facilities
CRN Submits Comments to FDA on Health Claims for Phytosterols and Risk of Coronary Heart Disease, Proposed Rule, Reopening of the Comment Period October 25, 2011 | Read more about CRN Submits Comments to FDA on Health Claims for Phytosterols and Risk of Coronary Heart Disease, Proposed Rule, Reopening of the Comment Period
CRN Submits Comments to FDA on Citizen Petition to Require Cautionary Statements On the Label of Dietary Supplements Containing St. John’s Wort January 5, 2012 | Read more about CRN Submits Comments to FDA on Citizen Petition to Require Cautionary Statements On the Label of Dietary Supplements Containing St. John’s Wort
CRN Submits Comments to FDA on Adverse Event Reporting and Recordkeeping for Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act May 21, 2012 | Read more about CRN Submits Comments to FDA on Adverse Event Reporting and Recordkeeping for Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act
CRN Calls on FDA to Reverse Its Current Position on Synthetic Botanicals October 22, 2012 | Download comments Read more about CRN Calls on FDA to Reverse Its Current Position on Synthetic Botanicals
CRN Letter to FDA on its Response to CRN Comments on Synthetic Botanicals December 4, 2012 | Read more about CRN Letter to FDA on its Response to CRN Comments on Synthetic Botanicals
CRN Submits Comments to FDA on 'Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues' Docket No. FDA-2011-D-0376 May 2, 2013 | Read more about CRN Submits Comments to FDA on 'Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues' Docket No. FDA-2011-D-0376
Comments Submitted on Behalf of CRN on Docket No. FDA-2011-D-0376; Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications 76 Fed. Reg. 3911, by Steptoe & Johnson LLP May 7, 2013 | Download comments (PDF) Read more about Comments Submitted on Behalf of CRN on Docket No. FDA-2011-D-0376; Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications 76 Fed. Reg. 3911, by Steptoe & Johnson LLP
CRN Submits Comments to FDA Docket No. FDA-2013-D-0880 Draft Guidance for Industry, Frequently Asked Questions About Medical Foods; Second Edition October 31, 2013 | Read more about CRN Submits Comments to FDA Docket No. FDA-2013-D-0880 Draft Guidance for Industry, Frequently Asked Questions About Medical Foods; Second Edition
